Literature DB >> 22825555

Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.

James L Gulley, Susan F Leitman, William Dahut, Jeffrey Schlom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22825555     DOI： 10.1093/jnci/djs280

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Demystifying immunotherapy in prostate cancer: understanding current and future treatment strategies.

Authors:  Ravi A Madan; James L Gulley; Philip W Kantoff
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

Review 2.  Immunotherapy for prostate cancer: recent developments and future challenges.

Authors:  Michael T Schweizer; Charles G Drake
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 3.  Dendritic cell vaccine therapy for colorectal cancer.

Authors:  Amanda L Wooster; Lydia H Girgis; Hayley Brazeale; Trevor S Anderson; Laurence M Wood; Devin B Lowe
Journal:  Pharmacol Res       Date:  2020-12-28       Impact factor: 7.658

Review 4.  Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy.

Authors:  Peter F Mulders; Maria De Santis; Thomas Powles; Karim Fizazi
Journal:  Cancer Immunol Immunother       Date:  2015-05-30       Impact factor: 6.968

5.  Prostate cancer vaccines: Update on clinical development.

Authors:  Sean M Geary; Aliasger K Salem
Journal:  Oncoimmunology       Date:  2013-04-29       Impact factor: 7.723

Review 6.  The Promise of Preventive Cancer Vaccines.

Authors:  Pier-Luigi Lollini; Federica Cavallo; Patrizia Nanni; Elena Quaglino
Journal:  Vaccines (Basel)       Date:  2015-06-17

Review 7.  Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm.

Authors:  James L Gulley; Peter Mulders; Peter Albers; Jacques Banchereau; Michel Bolla; Klaus Pantel; Thomas Powles
Journal:  Oncoimmunology       Date:  2015-12-10       Impact factor: 8.110
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.